Please login to the form below

Not currently logged in
Email:
Password:

MS

This page shows the latest MS news and features for those working in and with pharma, biotech and healthcare.

Biogen triumphs over Mylan’s Tecfidera patent challenge

Biogen triumphs over Mylan’s Tecfidera patent challenge

language. Although the patent dispute is an overwhelming win, Biogen has been facing other challenges in the MS market from new treatments, including Novartis’ newly-approved Mayzent and Roche’s Ocrevus. ... Biogen does, however, have its own

Latest news

More from news
Approximately 30 fully matching, plus 343 partially matching documents found.

Latest Intelligence

  • Case study: OptiMiSe for MS nurses Case study: OptiMiSe for MS nurses

    Timescale:N/A. In the UK, MS services have been impacted by changing clinical and NHS landscapes. ... More than half of MSSNs based in the UK are engaged in OptiMiSe, impacting over 60, 000 patients with MS.

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    Initially B-MS reported promising data for the combination therapy from a phase 3 trial called Checkpoint-227. ... B-MS withdrew its supplemental Biologics License Application (sBLA) in January this year, explaining that ‘further evidence on the

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    4. Mayzent – a latest addition to competitive MS market. Novartis’ Mayzent (siponimod) is expected to be launched in the US in Q1 for multiple sclerosis, with an EU launch to follow ... The company says its latest trial results are the first and

  • Case study: The World vs MS Case study: The World vs MS

    Multiple sclerosis (MS) is an incurable neurological condition affecting over 2.5 million people around the world. ... solving to turn their minds to MS and offer solutions to the challenges posed.

  • Case study: OptiMiSe – evidence-based methods for clinical behaviour change Case study: OptiMiSe – evidence-based methods for clinical behaviour change

    Timescale:N/A. MS specialist nurses have witnessed a revolution in treatment options for MS. ... Multiple sclerosis specialist nurses (MSSNs) play a critical role in providing individualised, coordinated care for people with MS (pwMS).

More from intelligence
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 46 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics